HEPION PHARMACEUTICALS, INC. Conversion of Stock, Shares Converted
HEPION PHARMACEUTICALS, INC. (HEPA) reported Conversion of Stock, Shares Converted of 52 shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2024-08-13
- HEPION PHARMACEUTICALS, INC. conversion of stock, shares converted for the quarter ending 2023-12-31 was 51.00 shares.
- HEPION PHARMACEUTICALS, INC. conversion of stock, shares converted for the quarter ending 2023-09-30 was 0.00 shares.
- HEPION PHARMACEUTICALS, INC. conversion of stock, shares converted for the quarter ending 2023-06-30 was 0.00 shares.
- HEPION PHARMACEUTICALS, INC. conversion of stock, shares converted for the quarter ending 2023-03-31 was 1.00 shares, a 50.00% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. conversion of stock, shares converted for fiscal 2023 was 52.00 shares, a 2500.00% increase from fiscal 2022.
- HEPION PHARMACEUTICALS, INC. conversion of stock, shares converted for fiscal 2022 was 2.00 shares, a 98.02% decline from fiscal 2021.
- HEPION PHARMACEUTICALS, INC. conversion of stock, shares converted for fiscal 2021 was 101.00 shares, a 9.78% increase from fiscal 2020.
- HEPION PHARMACEUTICALS, INC. conversion of stock, shares converted for fiscal 2020 was 92.00 shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 3 month as first filed | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 6 month as first filed | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 9 month as first filed | Conversion of Stock, Shares Converted 12 month | Conversion of Stock, Shares Converted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | 51.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 51.00 shares derived: sum of 2 quarters · filed 2024-04-16 | 51.00 shares derived: sum of 3 quarters · filed 2024-08-13 | 52.00 shares 10-K · filed 2024-04-16 | ||||
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | 0.00 shares derived: sum of 2 quarters · filed 2024-08-13 | 1.00 shares 10-Q · filed 2023-11-20 | 1.00 shares derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 1.00 shares 10-Q · filed 2024-08-13 | 1.00 shares derived: sum of 3 quarters · filed 2024-08-13 | 1.00 shares derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 1.00 shares 10-Q · filed 2024-05-21 | 1.00 shares derived: sum of 2 quarters · filed 2024-05-21 | 1.00 shares derived: sum of 3 quarters · filed 2024-05-21 | 1.00 shares derived: sum of 4 quarters · filed 2024-05-21 | ||||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 0.00 shares derived: sum of 2 quarters · filed 2024-04-16 | 0.00 shares derived: sum of 3 quarters · filed 2024-04-16 | 2.00 shares 10-K · filed 2024-04-16 | 46.00 shares 10-K · filed 2023-04-10 | |||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-20 | 2.00 shares 10-Q · filed 2023-11-20 | 46.00 shares 10-Q · filed 2022-11-14 | 2.00 shares derived: sum of 4 quarters · filed 2023-11-20 | |||
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 2.00 shares 10-Q · filed 2023-08-14 | 46.00 shares 10-Q · filed 2022-08-15 | 2.00 shares derived: sum of 3 quarters · filed 2023-08-14 | 11.00 shares derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | 2.00 shares 10-Q · filed 2023-05-12 | 46.00 shares 10-Q · filed 2022-05-16 | 2.00 shares derived: sum of 2 quarters · filed 2023-05-12 | 11.00 shares derived: sum of 3 quarters · filed 2023-05-12 | 11.00 shares derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | 9.00 shares derived: sum of 2 quarters · filed 2023-04-10 | 9.00 shares derived: sum of 3 quarters · filed 2023-04-10 | 101.00 shares 10-K · filed 2023-04-10 | ||||
| 2021-09-30 | 9.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 9.00 shares derived: sum of 2 quarters · filed 2022-11-14 | 101.00 shares 10-Q · filed 2022-11-14 | 101.00 shares derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 92.00 shares 10-Q · filed 2022-08-15 | 92.00 shares derived: sum of 3 quarters · filed 2022-08-15 | |||||
| 2021-03-31 | 92.00 shares 10-Q · filed 2022-05-16 | 92.00 shares derived: sum of 2 quarters · filed 2022-05-16 | ||||||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | 92.00 shares 10-K · filed 2022-04-08 | ||||||
| 2020-09-30 | 92.00 shares 10-Q · filed 2020-11-16 | |||||||
| 2019-06-30 | 85.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 131.00 shares 10-Q · filed 2019-08-14 | ||||||
| 2019-03-31 | 46.00 shares 10-Q · filed 2019-05-15 | |||||||
| 2018-12-31 | 8.85K shares 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |